Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers

Jennifer L. Shaffer, Jeffrey R. Petrella, Forrest Sheldon, Kingshuk Roy Choudhury, Vince D. Calhoun, R. Edward Coleman, P. Murali Doraiswamy, For the Alzheimer’s Disease Neuroimaging InitiativeRadiology 2012 · DOI

Abstract

Imaging and CSF biomarkers can improve prediction of conversion from MCI to AD compared with baseline clinical testing. FDG PET appears to add the greatest prognostic information.
BibTeX
@inproceedings{shaffer2012predicting,
  author = {Jennifer L. Shaffer and Jeffrey R. Petrella and Forrest Sheldon and Kingshuk Roy Choudhury and Vince D. Calhoun and R. Edward Coleman and P. Murali Doraiswamy and For the Alzheimer’s Disease Neuroimaging Initiative},
  title = {{Predicting Cognitive Decline in Subjects at Risk for Alzheimer Disease by Using Combined Cerebrospinal Fluid, MR Imaging, and PET Biomarkers}},
  booktitle = {Radiology},
  year = {2012},
  doi = {10.1148/radiol.12120010},
}

Loading related content...

Figure